The market has taken the world’s most-owned stock and, inside two months, compressed it to roughly 22–24x consensus NTM / FY27 earnings — not clearly below the S&P 500, but strikingly close to a market multiple for a company whose revenue just grew 85% year over year — on a be...
Read Article ›At roughly 41x FY27E earnings against that growth and that balance sheet, Robinhood is mispriced as a crypto proxy when the crypto line has already fallen to 13% of revenue and the business kept compounding anyway. The market is underwriting the wrong risk, and the diversifica...
Read Article ›The Q1 2026 print, the closed Apellis platform, and the explicit 2027 deleveraging path are the evidence that the growth story is no longer unproven — it is showing up in the revenue line and the cash flow. The pipeline readouts in late 2026 and 2027 are real and could break t...
Read Article ›On July 8, 2026, Deere settled the antitrust right-to-repair lawsuit brought by the FTC and five state attorneys general; under a stipulated order running ten years and subject to FTC oversight, Deere must give farmers and independent shops the same diagnostic and repair resou...
Read Article ›The reason to hold Costco through any multiple debate is that the membership line is not just growing — it is accelerating, and its quality is improving. Everyone agrees the franchise is elite. The contested question is whether 46x trailing earnings — roughly 40-42x forward — ...
Read Article ›The de-rating that took the stock from the high-$40s to $42 was a repricing of dividend reliability, not of asset quality — and the assets, the balance sheet and the well inventory are all in better shape now than when the stock was higher. At a high-single-digit cash yield wi...
Read Article ›The bull/bear standoff here is well worn — an elite compounding franchise trading at roughly 40x earnings against a structural share issuance overhang. That framing is the starting point, not the answer. What tips the balance is the cadence of the underlying metrics: account, ...
Read Article ›Copart just delivered revenue growth, margin expansion, and higher EPS despite falling insurance volumes, backed by record pure-sale penetration, a rising total-loss frequency that structurally feeds its inventory, and a global bidder base that props up per-car economics.
Read Article ›The private-credit fear that cut the stock by nearly 40% is aimed at roughly a twentieth of the platform. At ~15x forward adjusted earnings after a brutal drawdown, the confirmation risk over the next several quarters sits with the bears. This is a high-quality compounder on s...
Read Article ›The debate isn't whether URBN is a good business—it's whether the crowd re-rates it before the numbers force the issue. I think the setup into holiday, backed by buybacks and a conservatively built margin plan, tilts that resolution in shareholders' favor.
Read Article ›Amazon stock has slid back toward the low $240s even as AWS just posted its fastest growth in nearly four years. The bear case is simple and loud: capital spending has swallowed free cash flow. My argument is that this particular cash flow trough is the most defensible one Ama...
Read Article ›The standing critique of Rocket Lab is simple: elite growth, elite vision, no profits, and a valuation that requires everything to go right. The Iridium acquisition is the most direct possible response to that critique, because Iridium is the thing Rocket Lab has never had—a c...
Read Article ›The market spent two years treating Comcast as a structurally challenged broadband utility with a fading media albatross stapled to it, and priced it accordingly. The separation of NBCUniversal and Sky directly attacks that framing by letting a cash-rich, under-cross-sold conn...
Read Article ›What the selloff underweights is that Microsoft has run this play before — it absorbed margin compression during the first Azure buildout and methodically clawed it back as utilization improved — and this time it holds more levers. The first is silicon. Its Cobalt CPU is now d...
Read Article ›The familiar standoff—elite CF monopoly versus a full multiple and a maturing core—resolves in the buyers' favor once you weight the catalysts by how knowable they are. CF is converting toward ALYFTREK on a long exclusivity runway and funding everything else; that is the demon...
Read Article ›This is not a company watching solar demand evaporate; it is a premium hardware franchise re-routing US demand from cash sales onto TPO rails while monetizing a domestic-manufacturing credit annuity that peers can't match. The three things that decide the next two quarters are...
Read Article ›Hawaiian Electric has graduated from tail-risk to execution risk, and that is a genuine improvement in the quality of the investment. The legal cliff is behind it: the global settlement is final, the releases are effective, and the first $479 million installment is paid.
Read Article ›For most software companies past $5 billion in ARR, the law of large numbers grinds the growth rate of *incremental* bookings steadily lower. CrowdStrike did the opposite, and management leaned into it.
Read Article ›CarMax is deliberately reshaping its earnings mix — trading retail GPU for unit growth while attempting to fund the price competitiveness through cost rather than charity.
Read Article ›The central tension in Dexcom is whether its non-insulin type 2 expansion is a margin-accretive growth wave or a commoditization trap. The resolution is in the sequencing. The catalysts that drive the next several quarters — commercial coverage of all diabetics this summer, G7...
Read Article ›Duolingo is the rare consumer-software franchise that deliberately throttled its own near-term monetization to feed the top of its funnel — and the market has punished it as if the growth engine itself broke. The stock changes hands around **$123**, down roughly three-quarters...
Read Article ›